Sulfuric Acid

Sulfuric Acid

SCHEMBL724776

CN(C)C(=N)N.O=S(=O)(O)O

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CALCRLCHRM1CHRM2CHRM3F2RMAOAMAOBMAP2K1MAP2K2NTRK1NTRK2NTRK3OPRD1OPRK1OPRM1P2RY12PKLRSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASLC18A2SLC6A2SLC6A3TLR7TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8dacAdacBdacCfolAftsImrcAmrcBmrdApolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmB1rpmB2rpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmHrpmIrpmJrpmJ2rpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsR1rpsR2rpsSrpsTrpsUrpsZykgMykgO

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A known ✓ P35348 1/20 0.38
KDM4E B2RXH2 2/20 0.52
BLM P54132 2/20 0.52
NPSR1 Q6W5P4 2/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C19 P33261 1/20 0.52
CA5A P35218 2/20 0.38
CA5B Q9Y2D0 2/20 0.38
LMNA P02545 1/20 0.38
DPP4 P27487 1/20 0.38
F2 P00734 2/20 0.36
PRSS1 P07477 2/20 0.36
PRSS2 P07478 2/20 0.36
PRSS3 P35030 2/20 0.36
HTT P42858 1/20 0.36
CA2 P00918 3/20 0.33
CA1 P00915 2/20 0.33
TSHR P16473 1/20 0.33
NT5E P21589 1/20 0.33
CA4 P22748 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL1025495 1.00 KDM4E (0.52) KDM4EBLMNPSR1CYP2D6CYP2C19
Sulfuric Acid SCHEMBL9724618 0.85 KDM4E (0.50) KDM4EBLMNPSR1CYP2D6CYP2C19
Sulfuric Acid SCHEMBL10751111 0.85 KDM4E (0.50) KDM4EBLMNPSR1CYP2D6CYP2C19
SCHEMBL33703 0.83
SCHEMBL349631 0.83
Urea SCHEMBL28979500 0.80 LMNA (0.43) KDM4EBLMNPSR1CYP2D6CYP2C19
Bromide SCHEMBL27402570 0.79
Methane SCHEMBL28838054 0.79
Hydrochloric Acid SCHEMBL29018408 0.79
Guanidine SCHEMBL27115146 0.79 LMNA (0.45) LMNADPP4ADRA1AHTTHTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118272880-B Electroplating solution and electroplating method for damascene interconnection 深圳创智芯联科技股份有限公司 2024-07-30 CN claimed
CN-118272880-A Electroplating additive and electroplating method for damascene interconnection 深圳创智芯联科技股份有限公司 2024-07-02 CN claimed
CN-118207721-A Bleaching method of fiber material 武汉纺织大学 2024-06-18 CN claimed
CN-116440823-A Dimethylamine recovery device in production of hexazinone and recovery method thereof 安徽广信农化股份有限公司 2023-07-18 CN claimed
US-20160296449-A1 Semi-Permanent Hair Straightening Composition And Method LUBRIZOL ADVANCED MATERIALS, INC. 2016-10-13 US claimed
US-12521367-B2 Related formulations and methods related to eye irritation LEBRUN LABS LLC (US) 2026-01-13 US disclosed
US-20250389737-A1 FACTOR Xa REAGENT INSTR LABORATORY CO (US) 2025-12-25 US disclosed
EP-4667582-A1 FACTOR XA REAGENT Instrumentation Laboratory Company (US) 2025-12-24 EP disclosed
EP-3619204-B1 COMPOUNDS FOR THE TREATMENT OF RESPIRATORY DISEASES TIANLI BIOTECH PTY LTD (AU) 2025-10-01 EP disclosed
US-12415828-B2 Modified oligonucleotides and methods for their synthesis NOOGEN LLC (RU) 2025-09-16 US disclosed
US-12115147-B2 Formulations and methods related to eye irritation LEBRUN LABS LLC (US) 2024-10-15 US disclosed
CN-118272880-B Electroplating solution and electroplating method for damascene interconnection 深圳创智芯联科技股份有限公司 2024-07-30 CN disclosed
WO-1984000875-A1 ACYL GUANIDINES RORER INT OVERSEAS (US) 1984-03-15 WO disclosed
EP-0007066-B1 4-ALKYL- AND 4-ALLYL-THIO-, SULFINYL- AND SULFONYL-METHYL-2-AMINO-6-N,N'-DIMETHYLCARBAMOYLOXY PYRIMIDINES, PROCESS FOR THEIR PREPARATION, COMPOSITIONS CONTAINING THEM AND THEIR USE AS INSECTICIDES CIBA-GEIGY AG (CH) 1981-06-03 EP disclosed
EP-0019811-A1 Pyrimidine compounds, process for their preparation, pharmaceutical compositions containing them and their therapeutical use CIBA-GEIGY AG (CH) 1980-12-10 EP disclosed
US-4215122-A 4-Alkyl- and 4-allyl-mercapto-, -sulfinyl- and -sulfonyl-methyl-2-amino-6-N,N-dimethylcarbamoyloxy-pyrimidines, processes for producing them, compositions containing these pyrimidines, and the use thereof for controlling insect pests CIBA-GEIGY CORPORATION (US) 1980-07-29 US disclosed
EP-0007066-A1 4-Alkyl- and 4-allyl-thio-, sulfinyl- and sulfonyl-methyl-2-amino-6-N,N'-dimethylcarbamoyloxy pyrimidines, process for their preparation, compositions containing them and their use as insecticides CIBA-GEIGY AG (CH) 1980-01-23 EP disclosed
EP-0004644-A2 Pyrimidin(5)yl-(thiono)(thiol)-phosphoric(phosphonic) acid esters or amides, process for their preparation and their use as insecticides and acaricides BAYER AG (DE) 1979-10-17 EP disclosed
US-4147804-A ANTIARRHYTHMIA AGENTS WILLIAM H. RORER, INC. (US) 1979-04-03 US disclosed
US-4107301-A INSECTICIDES, ACARICIDES BAYER AKTIENGESELLSCHAFT (DE) 1978-08-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12415828-B2 Modified oligonucleotides and methods for their synthesis RNGTT, TYMP, POLM ADRA1A 4776/4885KDM4E 3964/4885BLM 512/4885
US-20250389737-A1 FACTOR Xa REAGENT F9, F11, TFPI ADRA1A 2672/4885KDM4E 566/4885BLM 1974/4885
US-20160296449-A1 Semi-Permanent Hair Straightening Composition And Method KRT18, PRKDC, DNMT1 ADRA1A 4056/4885KDM4E 425/4885BLM 2077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.